Kuros Biosciences AG (SWX: KURN)

Kuros Biosciences AG Revenue

Kuros Biosciences AG had revenue of 121.14M CHF in the half year ending June 30, 2024, a decrease of -58.85%. This brings the company's revenue in the last twelve months to 365.79M, down -44.72% year-over-year. In the year 2023, Kuros Biosciences AG had annual revenue of 576.91M, down -7.52%.

• Revenue (ttm): 365.79M
• Revenue Growth: -44.72%
• P/S Ratio: 9.40
• Revenue / Employee: 495.68K
• Employees: 106
• Market Cap: 633.39M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	576.91M	-46.94M	-7.52%
Dec 31, 2022	623.85M	209.80M	50.67%
Dec 31, 2021	414.06M	80.54M	24.15%
Dec 31, 2020	333.51M	-51.59M	-13.40%
Dec 31, 2019	385.10M	-8.17M	-2.08%